Clinical evidence development

This course examines the uses and limits of new methods for assessing health technologies in the early stages of research and development. Through real-world case studies and interactive learning, participants will learn how to frame the assessment, generate evidence, and produce insights relevant for decision-making, reflecting that information and implementation may be uncertain.

Explore how real-world evidence can inform value, affordability, and access decisions for cell and gene therapies.

Real World Evidence (RWE) has become an essential addition to Randomised Controlled Trials (RCTs) to further reduce regulatory, payer, physician and patient uncertainty. Unfortunately, many companies struggle implementing it. The key ingredient to success is a cross-functional organisation where managers have widespread knowledge of the fundamentals and a shared vocabulary. In this course you will learn the fundamentals of RWE so that you can contribute effectively when decisions are made and/or when implementing RWE studies.

Real World Evidence (RWE) has become an essential addition to Randomised Controlled Trials (RCTs) to further reduce regulatory, payer, physician and patient uncertainty. Unfortunately, many companies struggle implementing it. The key ingredient to success is a cross-functional organisation where managers have widespread knowledge of the fundamentals and a shared vocabulary. In this course you will learn the fundamentals of RWE so that you can contribute effectively when decisions are made and/or when implementing RWE studies.